Biocon share price rises 3% after block deal, Pertuzumab deal in Brazil

According to data compiled by Bloomberg, around 16.6 million shares of Biocon changed hands on the BSE in a single pre-market block trade.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.